Over the course of the first 2 weeks of July, the
price of Spodumeme Concentrate has declined
about $400 USD to $3610/mt, according to SMM.
Is this fall in price being engineered? or has demand
really declined?
Is SMM a reliable source?
Last year at around this time the price of
our stock started going on a real tear, partly as a function
of the high price of spodumeme. Are the shorts anticipating
that the cost of spod will continue to decline and drag our stock
price down as well. I can already hear the rantings from the investment
banks immediately after we release our quarterly report as they focus
entirely on our lower product sale price.
The next couple of months are going to be interesting to say the least.
Good News & Bad News, page-30792
-
- There are more pages in this discussion • 13,650 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PLS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$3.10 |
Change
0.100(3.33%) |
Mkt cap ! $9.030B | |||
| Open | High | Low | Value | Volume |
| $3.06 | $3.11 | $3.05 | $13.59M | 4.410M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 51569 | $3.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $3.11 | 283974 | 29 |
View Market Depth
| Last trade - 10.23am 17/07/2024 (20 minute delay) ? |
| PLS (ASX) Chart |